| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |